Structure Therapeutics CMO Blas Coll Crespo disposes of USD 124,008 common shares
Bitget2026/09/22 22:00- Structure Therapeutics Chief Medical Officer Blas Coll Crespo cut his ordinary share stake to 258,228 shares.
- Disposed of 10,626 ordinary shares on Sept. 18 at USD 11.67 per share through tax withholding tied to RSU vesting.
- Converted 12,024 ordinary shares into 4,008 American Depositary Shares on Sept. 21.
- Sold 4,008 American Depositary Shares on Sept. 21 at USD 36.15 under a Rule 10b5-1 plan.
- Held 1,157 American Depositary Shares following the transactions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Novo Nordisk (NVO.US) considers entering the hair loss market, seeking new growth points with its "post-Wegovy" strategy
Novo Nordisk is targeting the hair loss market, seeking to diversify its drug portfolio.
The growth of the traditional network equipment industry may have peaked! Piper Sandler lowers Cisco (CSCO.US) target price to 125 USD.
Piper Sandler analyst James Fish maintains a "Neutral" rating on Cisco, while lowering the target price from $132 to $125.
Runway Growth Finance director Edward J. Goldthorpe acquires USD 67,253.48 in common shares
Crypto prices
More
